• Targeting Type 1 Diabetes

  • Nov 21 2022
  • Duración: 17 m
  • Podcast
Targeting Type 1 Diabetes Por arte de portada

Targeting Type 1 Diabetes

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Madison Carter is a fearless investigative reporter. She takes no day for granted because she lives with type 1 diabetes (T1D). Dr. Doug Melton is a world-renowned stem cell researcher and distinguished fellow at Vertex – and his now grown children, Sam and Emma, live with T1D. Along with scientists like Dr. Felicia Pagliuca, who leads Vertex’s research into T1D, he’s been on a quest to help Madison, Sam, Emma, and others like them by investigating the disease at a cellular level. 

    Produced by Bloomberg Media Studios and Vertex Pharmaceuticals. 

     

    Featured guests:

    Madison Carter is an investigative journalist with 11Alive News, an NBC affiliate in Atlanta, GA. She's living with type 1 diabetes. 

    Aaron Kowalski is the President and CEO of JDRF. 

    Felicia Pagliuca is the Disease Area Executive, Type 1 Diabetes, at Vertex Pharmaceuticals

    Doug Melton leads investigations into treatments for Type 1 Diabetes at Vertex Pharmaceuticals. He is renowned for his stem cell research at Harvard University. Read more about Vertex's approach to targeting type 1 diabetes

    Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.
    Más Menos
Más Menos

Lo que los oyentes dicen sobre Targeting Type 1 Diabetes

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles